Under the vision of “empowering every user with accurate and convenient health management,” 30 scientists founded SIBIONICS in 2015. Today, SIBIONICS has become a world-leading Continuous Glucose Monitoring (CGM) brand, providing service and product in 96+ countries, serving 2.6 million users globally, collaborating with over 4,000 medical institutions, and holding more than 300 patents worldwide.
Beyond commercial success, technology should serve humanity. We pledge to cap our annual profit margin at a reasonable level, with any excess allocated to diabetes research, ensuring innovations truly benefit humans and society.
